These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

463 related articles for article (PubMed ID: 28739436)

  • 21. Cost-effectiveness of latent tuberculosis infection testing and treatment with 6-week regimen among key population in rural communities in China: a decision analysis study.
    Cao X; Guo T; Xin H; Du J; Yang C; Feng B; He Y; Shen L; Di Y; Li Z; Chen Y; Liang J; Jin Q; Wang L; Gao L
    Eur J Clin Microbiol Infect Dis; 2024 May; 43(5):809-820. PubMed ID: 38383889
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and outcome of treatment of latent tuberculosis infection in liver transplant recipients.
    Lee YW; Chung H; Kim SH; Sung H; Ha SM; Jwa EK; Jung DH; Moon DB; Lee SG; Lee SO
    Infection; 2024 Jun; 52(3):1055-1061. PubMed ID: 38347366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effectiveness of 3 months of rifampicin and isoniazid chemoprophylaxis for the treatment of latent tuberculosis infection in children.
    Bright-Thomas R; Nandwani S; Smith J; Morris JA; Ormerod LP
    Arch Dis Child; 2010 Aug; 95(8):600-2. PubMed ID: 20530147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Latent tuberculosis infection: Opportunities and challenges.
    Chee CBE; Reves R; Zhang Y; Belknap R
    Respirology; 2018 Oct; 23(10):893-900. PubMed ID: 29901251
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determinants of latent tuberculosis infection and treatment interruption in long-term care facilities: A retrospective cohort study in Taiwan.
    Chiu TF; Yen MY; Shie YH; Huang HL; Chen CC; Yen YF
    J Microbiol Immunol Infect; 2022 Dec; 55(6 Pt 2):1310-1317. PubMed ID: 34686442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors associated with treatment for latent tuberculosis in persons living with HIV/AIDS.
    Aquino DS; Moura LC; Maruza M; Silva AP; Ximenes RA; Lacerda HR; Miranda Filho Dde B; Albuquerque Mde F
    Cad Saude Publica; 2015 Dec; 31(12):2505-13. PubMed ID: 26872227
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-wide INH treatment of latent TB infection in a BCG-vaccinated population: experience in rural Taiwan.
    Bowerman RJ
    Int J Tuberc Lung Dis; 2007 Apr; 11(4):470-2. PubMed ID: 17394696
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Safety and treatment completion of latent tuberculosis infection treatment in the elderly population-A prospective observational study in Taiwan.
    Feng JY; Huang WC; Lin SM; Wang TY; Lee SS; Shu CC; Pan SW; Chen CY; Lin CB; Wei YF; Tung CL; Li CP; Su WJ
    Int J Infect Dis; 2020 Jul; 96():550-557. PubMed ID: 32434083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis and treatment of latent tuberculosis infection in patients undergoing treatment with immunobiologic agents: a four-year experience in an endemic area.
    Lopes DMA; Pinheiro VGF; Monteiro HSA
    J Bras Pneumol; 2019; 45(6):e20180225. PubMed ID: 31618298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effectiveness of isoniazid preventative therapy in reducing incidence of active tuberculosis among people living with HIV/AIDS in public health facilities of Addis Ababa, Ethiopia: a historical cohort study.
    Semu M; Fenta TG; Medhin G; Assefa D
    BMC Infect Dis; 2017 Jan; 17(1):5. PubMed ID: 28049455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latent tuberculosis infection: recent progress and challenges in South Korea.
    Jeon D
    Korean J Intern Med; 2020 Mar; 35(2):269-275. PubMed ID: 32131570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of latent TB infection in areas of high TB prevalence.
    Sharma SK; Mohanan S; Sharma A
    Chest; 2012 Sep; 142(3):761-773. PubMed ID: 22948580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling.
    Houben RM; Dodd PJ
    PLoS Med; 2016 Oct; 13(10):e1002152. PubMed ID: 27780211
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country.
    Dyrhol-Riise AM; Gran G; Wentzel-Larsen T; Blomberg B; Haanshuus CG; Mørkve O
    BMC Infect Dis; 2010 Mar; 10():57. PubMed ID: 20210999
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determinants of losses in the latent tuberculosis cascade of care in Brazil: A retrospective cohort study.
    Araújo NCN; Cruz CMS; Arriaga MB; Cubillos-Angulo JM; Rocha MS; Silveira-Mattos PS; Matos GM; Marques IMB; Espirito Santo ICP; Almeida LL; Andrade CM; Souza LA; Netto EM; Andrade BB
    Int J Infect Dis; 2020 Apr; 93():277-283. PubMed ID: 32081776
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of tuberculosis infection in psoriatic patients on anti-TNF therapy: report of a case series with 144 patients.
    Sánchez-Moya AI; Dauden E
    J Eur Acad Dermatol Venereol; 2011 Jun; 25(6):730-3. PubMed ID: 21564322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Screening for Latent Tuberculosis Infection in People Living with HIV: TUBHIVIT Project, a Multicenter Italian Study.
    Pipitò L; Ricci ED; Maggi P; De Socio GV; Pellicano GF; Trizzino M; Rubino R; Lanzi A; Crupi L; Capriglione I; Squillace N; Nunnari G; Di Biagio A; Bonfanti P; Cascio A;
    Viruses; 2024 May; 16(5):. PubMed ID: 38793658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contact investigation in healthcare personnel exposed to pediatric patients with pulmonary tuberculosis at the pediatric ward, Vajira hospital, Thailand.
    Kanjanaphan T
    Indian J Tuberc; 2023; 70 Suppl 1():S72-S75. PubMed ID: 38110264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three months of weekly rifapentine plus isoniazid for latent tuberculosis treatment in solid organ transplant candidates.
    Knoll BM; Nog R; Wu Y; Dhand A
    Infection; 2017 Jun; 45(3):335-339. PubMed ID: 28276008
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.